BRUSSELS – As the European Union surpassed 500,000 people lost to the virus, the EU Commission chief said Wednesday that the bloc's much-criticized vaccine rollout could be partly blamed on the EU being over-optimistic, over-confident and plainly “late."
European Commission President Ursula von der Leyen defended the EU’s overall approach of trying to beat the pandemic with a unified vaccine plan for its 27 nations, even if she admitted mistakes in the strategy to quickly obtain sufficient vaccines for its 447 million citizens.
“We are still not where we want to be. We were late to authorize. We were too optimistic when it came to massive production and perhaps we were too confident that, what we ordered, would actually be delivered on time," von der Leyen told the EU parliament.
On the vaccine authorization, which left the EU three weeks behind Britain in starting its vaccination campaign, von der Leyen promised action. She said the EU would launch a clinical trial network and adapt the approval process to get doses quicker from the labs into the arms of a needy population.
“It's is true there are also lessons to be drawn from the procedure we have followed. And we are already drawing them," she told legislators.
The European Medicines Agency has approved three coronavirus vaccines for the bloc so far — from Pfizer-BioNTech, Moderna and Oxford-AstraZeneca — and is reviewing others.
Despite weeks of stinging criticism as the EU's vaccine campaign failed to gain momentum compared to Britain, Israel and the United States, the main parties in the legislature stuck with von der Leyen's approach of moving forward with all member states together.
“The key decisions were right," said Manfred Weber, the leader of the Christian Democrat European People's Party.